PUBLISHER: Grand View Research | PRODUCT CODE: 1511937
PUBLISHER: Grand View Research | PRODUCT CODE: 1511937
The global animal intestinal health market size is expected to reach USD 7.40 billion by 2030, at a projected CAGR of 7.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. Primary market growth drivers include rising R&D initiatives and the emergence of substitute products for animal intestinal health. Key industry participants are engaging in research activities to approach intestinal health complications in a more structured and scientific manner by creating knowledge bases and recommendations for both veterinarians & animal owners. This will boost the innovative spirit of the market and assist in the development of novel products that enhance the current gut health treatment regimes.
For instance, in April 2024, Nestle introduced the Petivity Microbiome Analysis Kit, which employs stool samples to provide customized information regarding the gut health of companion animals such as dogs and cats. This makes it possible for the experts to modify the nutrition and supplements according to every pet's microbiome. With more than a decade of research behind it, the kit makes assumptions about the health of the pet's digestive system. These developments offer proactive solutions for professionals seeking ways to enhance pet's well-being, presenting a holistic approach to pet care.
Furthermore, a worldwide study was conducted in 2021, which studied the gut microbiota in poultry worldwide. This Agrifutures Ag study acknowledged that the productivity of layer flocks relies on the gut microbiota and provided comprehensive data on the normal baseline composition of the gut microbiota in healthy layer poultry in cage, barn, and free-range systems.
Future research on gut health, such as an assessment of gut health therapies and techniques for expanding the duration of egg production and preserving egg quality during the lay, can be designed upon the findings of this project.
The industry leaders are encouraging research culture in this industry by investing in startups and other promising ongoing research studies to translate them into commercial animal well-being solutions. For example, in 2021, Cargill invested in a California, U.S.-based startup known as AnimalBiome. This company aims to develop solutions that can diagnose, restore, and maintain the gut health of companion animals like dogs, cats & horses. The company has thorough research backing of over 20 years in animal microbiome research. Such market developments portray a promising future for animal intestinal health.